Please provide your email address to receive an email when new articles are posted on . There was no previous standard, accepted definition for remission in asthma. The panel unanimously supported ...

Not only do biologics have good clinical traction — particularly on the risk of having an asthma attack, which is significantly reduced on biologics — but also improvement in symptoms, lung function, ...

In patients with moderate-to-severe allergic asthma, tezepelumab yields the greatest reduction in exacerbations among ...

Improvement across all asthma control parameters was achieved after 12 months of biologic treatment, according to one study. Patients with severe asthma treated with either omalizumab, benralizumab, ...

Dupilumab reduces mucus plugging and improves lung function in patients with moderate-to-severe type 2 asthma.

About 30 to 40% of children with asthma experience sleep difficulties due to symptoms like coughing and wheezing. Poor sleep ...

Among patients with severe asthma with low eosinophils untreated with biologics, there is a high burden of disease among those who have suboptimal disease control. Objectives: To quantify the clinical ...

Spontaneous pneumomediastinum (SPM) refers to the presence of free air in the mediastinum without preceding trauma or ...

Nektar Therapeutics (NASDAQ:NKTR) shares climbed 3.6% on Monday after the biotech firm unveiled encouraging new data showing ...

The clinical study will evaluate the impact of Aptar Digital Health’s Respiratory Disease Management Platform on adult asthma patients CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar Digital Health, a ...